1. Bluming, A. Z., Vogel, C. L., Ziegler, J. L., Mody, N., Kamya, G.: Immunological effects of BCG in malignant melanoma: Two modes of administration compared. Ann. Intern. Med. 76, 405 (1972)
2. Fidler, I. J., Budmen, M. B., Hanna, Jr., M. G.: Characterization of in vitro reactivity by BCG-treated guinea pigs to syngeneic line-10 hepatocarcinoma. Cancer Immunity and Immunotherapy. 1, 179 (1976)
3. Gutterman, J. U., McBride, C., Freireich, E. I., Mavligit, G., Frei, E., Hersh, E. M.: Active immunotherapy with BCG for recurrent malignant melanoma. Lancet 1, 1208 (1973a)
4. Gutterman, J. U., Mavligit, G., McBride, C., Frei, E., Hersh, E. M.: Immunoprophylaxis of malignant melanoma with systemic BCG: Study of strain, dose and schedule. Natl. Inst. Cancer Monogr. 39, 205 (1973b)
5. Hanna, Jr., M. G., Peters, L. C.: Efficacy of intralesional BCG therapy in guinea pigs with disseminated tumor. Cancer 36, 160 (1975)